000 02397 a2200637 4500
005 20250518001232.0
264 0 _c20190528
008 201905s 0 0 eng d
022 _a2468-1253
024 7 _a10.1016/S2468-1253(18)30269-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRomera, Alvaro
245 0 0 _aBevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial.
_h[electronic resource]
260 _bThe lancet. Gastroenterology & hepatology
_c12 2018
300 _a845-855 p.
_bdigital
500 _aPublication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAntibodies
_xblood
650 0 4 _aAntineoplastic Agents, Immunological
_xadverse effects
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aArea Under Curve
650 0 4 _aBevacizumab
_xadverse effects
650 0 4 _aBiosimilar Pharmaceuticals
_xadverse effects
650 0 4 _aCamptothecin
_xanalogs & derivatives
650 0 4 _aColorectal Neoplasms
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aIntention to Treat Analysis
650 0 4 _aLeucovorin
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Metastasis
650 0 4 _aOrganoplatinum Compounds
_xtherapeutic use
650 0 4 _aProgression-Free Survival
650 0 4 _aTherapeutic Equivalency
700 1 _aPeredpaya, Sergiy
700 1 _aShparyk, Yaroslav
700 1 _aBondarenko, Igor
700 1 _aMendonça Bariani, Giovanni
700 1 _aAbdalla, Kathia Cristina
700 1 _aRoca, Enrique
700 1 _aFranke, Fábio
700 1 _aMelo Cruz, Felipe
700 1 _aRamesh, Anita
700 1 _aOstwal, Vikas
700 1 _aShah, Pradeep
700 1 _aRahuman, Sajeed Abdul
700 1 _aParavisini, Alexandra
700 1 _aHuerga, Camino
700 1 _aDel Campo García, Ana
700 1 _aMillán, Susana
773 0 _tThe lancet. Gastroenterology & hepatology
_gvol. 3
_gno. 12
_gp. 845-855
856 4 0 _uhttps://doi.org/10.1016/S2468-1253(18)30269-3
_zAvailable from publisher's website
999 _c28881195
_d28881195